ROYALTY PHARMA PLC's ticker is RPRX and the CUSIP is G7709Q104. A total of 233 filers reported holding ROYALTY PHARMA PLC in Q2 2021. The put-call ratio across all filers is 1.38 and the average weighting 1.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $5,612,446 | +53.8% | 209,576 | +75.7% | 0.02% | +56.2% |
| Q2 2023 | $3,648,003 | +15.3% | 119,294 | +36.9% | 0.02% | +6.7% |
| Q1 2023 | $3,162,928 | +16.8% | 87,133 | +27.2% | 0.02% | +7.1% |
| Q4 2022 | $2,708,068 | +13.2% | 68,524 | +15.0% | 0.01% | 0.0% |
| Q3 2022 | $2,393,000 | +15.6% | 59,561 | +21.0% | 0.01% | +16.7% |
| Q2 2022 | $2,070,000 | +7.8% | 49,242 | -0.1% | 0.01% | +33.3% |
| Q1 2022 | $1,920,000 | +35.8% | 49,278 | +38.8% | 0.01% | +28.6% |
| Q4 2021 | $1,414,000 | +31.7% | 35,491 | +21.3% | 0.01% | +16.7% |
| Q3 2021 | $1,074,000 | -11.2% | 29,270 | -0.5% | 0.01% | -14.3% |
| Q2 2021 | $1,210,000 | -5.7% | 29,413 | 0.0% | 0.01% | -12.5% |
| Q1 2021 | $1,283,000 | +5.6% | 29,413 | +21.2% | 0.01% | +14.3% |
| Q4 2020 | $1,215,000 | – | 24,271 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SIGULER GUFF ADVISERS, LLC | 6,761,970 | $244,378,000 | 79.54% |
| Vantage Consulting Group Inc | 7,862,542 | $284,152,000 | 60.85% |
| Memorial Sloan Kettering Cancer Center | 2,680,644 | $96,878,000 | 60.36% |
| Indie Asset Partners, LLC | 701,323 | $25,346,000 | 20.53% |
| HARVARD MANAGEMENT CO INC | 7,142,856 | $258,143,000 | 15.13% |
| Bleichroeder LP | 1,115,980 | $40,332,000 | 6.55% |
| Overbrook Management Corp | 785,132 | $28,375,000 | 6.16% |
| Geo Capital Gestora de Recursos Ltd | 194,305 | $7,022,000 | 3.21% |
| Brown University | 621,759 | $22,470,000 | 3.05% |
| Graypoint LLC | 610,584 | $22,067,000 | 2.71% |